Rate of lung function decline slows in the 3 years after targeted lung denervation in COPD

Affiliations

• ¹ Department of Pulmonary Diseases, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands; Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands. Electronic address: j.hartman@umcg.nl.
• ² Imperial College London, London, United Kingdom; Royal Brompton Hospital, London, United Kingdom.
• ³ CHU Grenoble Alpes, Service Hospitalier Universitaire Pneumologie Physiologie, Pôle Thorax et Vaisseaux, France; Universite Grenoble Alpes, Grenoble, France.
• ⁴ Department of Pulmonary Diseases, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands; Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
• ⁵ Thoraxklinik and Translational Lung Research Center Heidelberg, University of Heidelberg, Dep. of Pneumology and Critical Care Medicine, Heidelberg, Germany.
• ⁶ Karl-Landsteiner-Institute for Lung Research and Pulmonary Oncology, Klinik Floridsdorf, Vienna Healthcare Group, Vienna, Austria.
• ⁷ CHU Grenoble Alpes, Service Hospitalier Universitaire Pneumologie Physiologie, Pôle Thorax et Vaisseaux, France.